GTC Diabetes Summit 2013

Novel Treatment for Diabetic Dyslipidemia: Rapid and Robust Lowering of LDL, Non-HDL Cholesterol, Apolipoprotein B and Triglycerides after Multiple Doses of MGL-3196, Liver-Directed Thyroid Hormone Receptor-ß Agonist in Phase 1 Studies
April 29-30, 2013 | Boston, MA